World Vaccine Congress Europe 2022: meet our partners!
World Vaccine Congress Europe 2022: Chats with Chaudhrey
World Vaccine Congress Europe 2022: meet our exhibitors!
World Vaccine Congress Europe 2022: meet our sponsors!
World Vaccine Congress Europe 2022 trailer!
World Vaccine Congress 2022 Washington reel!
World Vaccine Congress 2020 invitation!
World Vaccine Congress Washington 2019 trailer!
No post found
MOST POPULAR THIS MONTH
EU grant advances universal DeltaFLU vaccine development
A grant of €7.6 million from the European Union will contribute to the efforts of a consortium of academic and industry partners that is advancing the development of a universal influenza vaccine. The FLUniversal programme will set out to conduct clinical trials of...
DRIVing vaccine innovation with Dr Sandeep Patel
Our next interview from the Congress last month was a recorded conversation with BARDA's Dr Sandeep Patel. Dr Patel joined us for the Biodefence workshop, presenting a session before moderating a panel. We were glad that he made time to join us and give an insight...
CEPI and aVaxziPen partner on vaccine delivery for access
CEPI and aVaxziPen Ltd announced in June 2023 that they are partnering to advance the development of two vaccine candidates that use aVaxziPen’s solid-dose vaccine delivery platform. CEPI is set to provide up to $1.6 million to establish proof-of-concept for...
Moderna and Merck announce positive DMFS results from trial
In June 2023 Moderna and Merck, who have been collaborating on a Phase IIb study to evaluate mRNA-4157 (V940), announced distant metastasis-free survival (DMFS) results. The trial investigates the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, with an...
Novavax and Gates partner for adjuvant in vaccine research
Novavax announced in June 2023 that it has signed a three-year agreement with the Bill and Melinda Gates Medical Research Institute to provide its Matrix-M™ adjuvant for use in preclinical vaccine research. The adjuvant is an element of Novavax’s COVID-19 vaccine and...
VaxEquity and CPI announce Innovate UK manufacturing grant
In June 2023 VaxEquity and CPI announced a grant of around £700k from Innovate UK, which will fund a collaborative project to advance RNA vaccines and therapeutics manufacturing. VaxEquity is a UK-based biotechnology company dedicated to the development of...
Transgene presents positive cancer vaccine data for HPV
French-based biotechnology company Transgene announced in June 2023 that new data confirm that its novel investigational therapeutic cancer vaccine can induce immune responses against HPV16. The results are presented in a poster at the American Society of Clinical...
Meeting unmet medical needs with Valneva’s Thomas Lingelbach
Next in our series of conversations with experts at the World Vaccine Congress last month is founding CEO of Valneva, Thomas Lingelbach. Thomas joined us for a conversation about the many field-leading vaccines that his team is working on. We were glad to secure some...